台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.05
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    586
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/12 ~ 2024/04/26     後一日»

券商獲利排行 - 2024/04/12 ~ 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.86%1,138.41,709-570.65502,1471,59728.528.129.227.1
  2.28%290.5137.8152.6-31015746727.326.727.527.1
  5.03%269.50269.5-188018828.5028.527.1
  0.84%269.132.3236.8-2908561,14727.827.827.927.1
  0.86%236.956180.9-2857171,00227.727.627.727.1
  3.74%219.141.7177.410922912025.525.425.827.1
  4.18%208.40.1208.3-1314217428.628.628.627.1
  7.07%192.466.1126.3-60359528.627.329.227.1
  2.75%174.288.186.1-11611323027.52727.827.1
  8.43%167.120.5146.5-52146729.628.329.827.1
  5.77%136.712.5124.2-63198228.928.42927.1
  5.50%134.864.570.3-54348827.826.528.427.1
  2.96%133.119.7113.4-1382316227.82727.927.1
  6.89%130.815.9114.9-6066628.726.32927.1
  0.77%127.45.6121.7-5604960927.327.227.327.1
  3.38%117.9100.417.5-1311112527.927.428.327.1
  10.59%115.6115.60039392826.529.427.1
  6.58%11555.859.2-34286228.226.828.827.1
  7.03%111.111100.1-41125429.328.529.427.1
  5.99%109.544.565-42236528.126.728.627.1
  5.55%108.167.640.5-23466928.227.328.827.1
  10.55%108.125.582.7-2963529.325.729.927.1
  8.45%91.142.149-22153828.426.429.227.1
  9.82%9145.445.6-1616322927.129.927.1
  3.82%80.749.231.5-20547528.227.628.527.1
  6.27%80.220.959.3-24194429.128.329.427.1
  1.98%80.1116.3-36.2461439728.327.82927.1
  6.76%77.620.357.3-27124028.727.429.127.1
  2.51%75.15916.1-179110827.727.32827.1
  4.56%69.856.113.632562427.326.62927.1
  4.98%67.554.712.820503027.126.428.227.1
  2.13%67.164.62.61611610027.226.927.527.1
  10.54%65.464.60.82222028.226.729.927.1
  5.26%64.29.155.1-3674328.427.328.627.1
  5.86%615.455.7-2783628.928.42927.1
  3.07%60.718.642.1-43287127.827.42827.1
  4.66%59.141.417.6-11344528.127.428.727.1
  3.15%58.214.144.1-3927662827.728.227.1
  6.24%55.216.838.5-19113128.627.42927.1
  0.87%54.133.720.4157229722726.927.427.1
  5.22%53.95.348.6-2783628.728.128.827.1
  5.40%53.236.217-10253528.127.328.827.1
  0.54%53.1-2.355.5-9825635427.627.627.627.1
  4.54%51.434.217.1-16254127.626.828.127.1
  6.75%51.30.950.4-2332629.22929.227.1
  2.11%499.939.18287526.726.628.627.1
  2.71%46.939.27.7-10536327.527.127.827.1
  5.35%462.643.4-2553028.728.328.827.1
  3.92%45.221.823.4-17244128.127.528.427.1
  6.50%43.12.540.6-2022328.927.72927.1

券商虧損排行 - 2024/04/12 ~ 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -3.62%-369.7-47.2-322.52803638328.128.227.627.1
  -8.72%-286.5-10.9-275.6104111729.629.728.127.1
  -4.25%-232.1-69.8-162.3-1673920726.427.926.127.1
  -5.85%-184.1-188.84.7-129911128.329.327.427.1
  -6.46%-180.9-171.7-9.25100952828.927.127.1
  -2.24%-165.8-157.8-8-6220927227.327.726.927.1
  -4.71%-131.2-86.4-44.8341006627.828.427.127.1
  -1.95%-122.4-105.4-17-4418923326.927.226.727.1
  -9.31%-118.3-11.2-107.13943429.629.82727.1
  -7.72%-98.5-19.5-793344102929.427.427.1
  -3.28%-90.3-79.8-10.59999027.828.227.327.1
  -4.57%-86.9-9-77.955671228.428.527.727.1
  -5.28%-86.4-72.5-13.95575128.729.427.927.1
  -4.71%-85.4-8-77.45564928.328.527.627.1
  -5.33%-84.7-75.4-9.36575127.928.627.127.1
  -5.70%-83.6-12.6-70.938511328.728.927.927.1
  -3.50%-83.2-80.8-2.4688822727.526.527.1
  -6.30%-79.3-79.300444527.928.927.127.1
  -5.11%-78.2-64.6-13.6-28285627.328.926.627.1
  -6.68%-73.7-46.1-27.614392528.32927.227.1
  -5.03%-73.6-9.2-64.436511528.728.828.227.1
  -4.08%-72.5-56.4-1621654427.327.826.527.1
  -4.07%-71.8-71.3-0.5-6576427.628.22727.1
  -7.81%-69.2-67.3-2-1333426.127.125.127.1
  -6.40%-65.2-54.8-10.45363128.329.127.427.1
  -2.96%-63.2-27-36.2-57228026.727.726.427.1
  -4.06%-62.8-1.6-61.35455128.228.226.627.1
  -6.01%-59.5-20.3-39.222351228.328.827.127.1
  -6.02%-57.30-57.33233128.828.828.927.1
  -7.09%-56.6-23.9-32.716281228.529.127.127.1
  -2.85%-56.40.3-56.76871327.927.92827.1
  -4.11%-54.7-33.8-20.9946372929.428.527.1
  -3.42%-53.2-30.7-22.422563427.728.127.227.1
  -5.83%-52.3-50.5-1.8132312828.827.227.1
  -4.72%-50.7-32.1-18.611382728.228.727.627.1
  -2.56%-50.3-19.6-30.825704528.128.327.827.1
  -1.90%-48.2-6.1-42.1-9329526.729.726.627.1
  -6.60%-47.80-47.8252502929027.1
  -3.91%-46.4-6.7-39.828421328.328.427.927.1
  -4.66%-46.4-12.5-33.814342029.229.528.827.1
  -4.37%-46.21.1-47.33237528.628.528.827.1
  -9.71%-45.5-43.7-1.81171627.628.926.227.1
  -4.87%-45.5-19.5-25.916331728.328.727.527.1
  -3.90%-45.2-10.3-34.917402328.929.128.727.1
  -5.34%-44.9-27.6-17.311301928.128.627.227.1
  -4.77%-44.8-17.1-27.716331728.428.827.827.1
  -4.68%-44.7-45.71-3313428.128.927.427.1
  -5.48%-43.4-19.7-23.713281428.328.727.327.1
  -6.01%-42.9-40.3-2.6-6202627.528.626.627.1
  -6.36%-42.50.2-42.722231292929.227.1
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章